Countries
Industry
Startup stage
Startup size
Funding
Impact startup SDGs
Showing: 3493 filtered startups

Archii

We are a legal tech company who are building Archii - an AI company secretary that automatically finds and organizes your legal and financial documents, while providing you business intelligence based on those documents.  We are a group of lawyers, document experts and software developers - several of us with a focus on machine learning and NLP. Together we are building a world-class AI software. Visit Archii.ai and read more about our mission and see our team. To create a great product, we need the right people on board. We are highly collaborative and always encourage people to speak out their mind. As a growing startup, we take care of our company culture in all our HR initiatives and introduce to every new comer how is to work at Archii.From day one, there is room for creativity, passion and impact. We do enjoy challenges and be challenged. We encourage our employees to find solutions to problems and take initiative to make things happen in our company.

Saninudge

Saninudge is a healthcare technology company, our mission is to eliminate Hospital Acquired Infections, a leading cause of death in the entire world. We design and market the only comprehensive hand-hygiene performance system which combines sensor networks with nudging technology to provide a complete, long-term and cost-effective hand hygiene system for healthcare institutions. You should apply for a job at Sani nudge if you want to have a job in a fast moving, intense company with the smartest people in the healthcare industry. We focus on reducing stress and improve quality of experience for all working on the project. Company facts We have more than 5,000 active sensors installed in hospitals. They have registered +2,000,000 hand sanitations and +100,000 patient interactions. They help +1,000 healthcare workers ensure proper hand hygiene compliance. We help hospitals and nursing homes in 7 European countries have clean hand when treating patients. We work with the largest healthcare companies in the world

TAG-IT

TAG-IT is a lost and found service. By the use of unique ID tags TAG-IT helps lost things back to the owner. TAG-IT doesn't require a monthly subscription nor batteri - TAG-IT is simply powered by helpfull people around the world. TAG-IT Pro is TAG-IT for proffessionals. Beside the ability to get lost things back, TAG-IT Pro is a subscription web/app based solution that helps companies in the construction business to save money and workhours by keeping track of tools, gear and safety equipment.

Venture Cup

Venture Cup’s mission is to identify and develop the talents and technology of tomorrow. We are an association of the Danish universities and we work to promote entrepreneurship among university students. We host two national startup competitions annually, a University Startup World Cup with teams from all over the world, Scandinavia’s largest Startup Mentors program for university students and the program Nordic HealthTech Talents with the support of Novo Nordisk Foundation.

My4

My4 is a social betting platform for true football fans!Our ambition is to revolutionize the way we bet on sports by creating superior peer-to-peer betting experiences. The My4 app launched in Denmark April 2017 and has since maintained a steady presence among the 20 most popular sports apps. In 2018, we're looking to expand to the UK and potentially other markets.We are located in the vibrant startup hub Founders House, Copenhagen, where we share offices with more than 30 other tech-startups.

Pinstriped

Pinstriped is a powerful SaaS product which has just launched from Beta, already has paying users and with numbers growing daily. We currently have a macOS app and are building out a web app.We make it easy for the person calling the meeting to take ownership, prepare an agenda and ensure the meeting is decision-focused, instead of discussion-focused. Pinstriped is your easy way to prepare and run successful meetings

Dixa

Dixa is a global customer service tech company on a mission to create friendships between brands and their customers, break down technology silos and eliminate bad customer service.Dixa is a truly international company with 14+ nationalities working together in the heart of Copenhagen and with offices in London, Berlin and Kiev. With customers in 20+ countries, Dixa has experienced incredible growth since it’s launch in 2018, quickly becoming one of Scandinavia’s fastest growing SaaS companies.

NORD.investments A/S

NORD.investments blev stiftet, som en reaktion mod bankernes dyre og komplekse investeringsprodukter. Vi er en fintech virksomhed, der i samarbejde med Saxo Bank, tilbyder en nem og enkel investeringsløsning. Vi søger løbende talenter til vores team, så hold dig ikke tilbage med at tage kontakt til os, hvis du vil med på rejsen. Mød os på NORD.investments!

Testing

TestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTestingTesting

Test Startup 11_2_3_4_5_6

Add a description between 300 and 4000 charactersAdd a description between 300 and 4000 charactersAdd a description between 300 and 4000 charactersAdd a description between 300 and 4000 charactersAdd a description between 300 and 4000 charactersAdd a description between 300 and 4000 charactersAdd a description between 300 and 4000 characters

Edison Systems ApS

Edison is a startup selling photovoltaic systems for private consumers. We want to make the world green through an attractive offering of green products for the home, and in longer term for businesses and on a grid scale as well. We are a new startup with an experienced founder base with +8 years in the industry.

Mendonca Biomed

Mendonca Biomed is an early stage life science startup with the aim to develop and validate novel biomarker for the early detection of viral infections in blood with an affordable yet simple detection method that can be universally applied. The company was originally founded by myself Kevin Mendonca in India based on his 15 years of accumulative research knowledge. Preliminary data on the utility of viral miRNA biomarkers for the screening of blood for transfusion transmitted viral infections, which are potentially superior to the currently available markers, and a simplified assay that is cost effective and can be universally adapted, were developed in India. However, due to an innate lack of infrastructure and funding opportunities in India, I applied for the startup Denmark program to move the company to the medicon valley. I recently moved to Demark, registered a privately owned company and currently in pursue of funding to validate the viral miRNA biomarkers for the early detection of HIV, HBV and HCV in donated blood. Around the world, more than 92 million blood donations are collected every year. Screening of donated blood and derived products, for HIV, HBV and HCV is mandatory worldwide. Screening is a key safety measure in protecting recipients from transfusion transmitted infections, especially in developing nations in Africa and Asia, where the donated blood is not processed because of high costs and lack of infrastructure. Moreover, in emergency situation like natural calamities, disasters and sudden outbreaks, the currently available methods are inadequate for on-site screening. Serological testing (antigen and antibody detection assays) have historically been the foundation of blood screening but with huge drawbacks of long window periods. Newer strategies like the PCR based amplification viral genomic DNA/RNA in blood have helped shorten the window period but have not eliminated it. PCR assays have also been known to fail in low viremia and/or suboptimal amplification efficiency. They are far more expensive than the serological assay, requires expertise, specialized equipment and a molecular biology setup, which is not available in the resource poor settings of the developing countries. Our solution is to develop and validate novel viral miRNA biomarkers that have the potential to further reduce the window period and use the unique characteristics of these biomarkers to develop a simple, multiplex (3 in 1), inexpensive probe hybridization assay that can be universally utilized in all settings and conditions. Viral miRNA molecules are easy to validate as biomarkers since the presence of vmiRNA’s is a definite indicator of infected cells. Benefit: Multiplex 3 in 1 test. Method as simple to perform as the serological assay with the benefits of a molecular assay. Can be adapted in any setting, even in the field and low resource conditions in developing nations. Potentially, lower window period of detection compared to any biomarkers that are available in the market currently. Value: High throughput, lower turnover time with lower chances of human error. Advantages of a molecular assay with the simplicity and affordability of a serological assay. Does not require specialized setup, infrastructure and highly trained technicians. Potentially, could detect the infections faster than any other tests in the market, lowering the risk of transfusion transmission. Once this platform has been validated, the product line can be expanded to cover all commercially viable viral infections. A HPV assay based on this platform, for example, could be a potential replacement for the invasive PAP test, and can be performed during a routine blood test. The platform can be further adapted to screen for novel viral infections like SARS, MERS, ZIKA etc. It can be also be developed to screen and control other sporadic outbreaks the like Dengue, Chikungunya etc.

NUKIGA

NUKIGA faciliterer værdiskabende partnerskaber mellem iværksættere, virksomheder og studerende. Vi udvikler et virtuelt væksthus, og vi skaber ny viden om Grønland i Danmark gennem en række kulturelle projekter. Dialog og partnerskaber opstår, når mennesker mødes enten fysisk eller online. Vores arbejde er derfor funderet i både fysiske såvel som online events og projekter.

hiveonline

hiveonline is a fintech startup headquartered in Copenhagen, Denmark, with subsidiaries in Stockholm, Sweden and Kigali, Rwanda, where our development team is located. We give communities of unbanked businesses, primarily women led, access to formal finance through a digital reputation. We are supporting village savings groups with blockchain technology with our MVP accounting app, and building on this to help cooperatives, agricultural associations and their members create more sustainable farming communities. We are expanding from Niger into Mozambique and other African countries.

Mads Olesen Holdings

Mads Olesen Holdings is owned by entrepreneur Mads Andreas Olesen. After selling his first companies for more than 100 mio. kroner, he now invests in startups, real estate and more through Mads Olesen Holdings (CVR: 36917997) and subsidiaries. In 2020, Mads Olesen Holdings invested in more than 50 ecommerce businesses through its investment in MXNEY.io, that specializes in alternative ecommerce funding. In 2021, the holding company is looking to add 10 properties to its current portfolio of 19 rental properties.